RecruitingNCT04864171

REASSURE-NIRS Registry

REvelation of PAthophySiological PhenotypeS of VUlneRable Lipid-Rich PlaquE on Near-InfraRed Spectroscopy: REASSURE-NIRS

Sponsor

National Cerebral and Cardiovascular Center, Japan

Enrollment

2,000 participants

Start Date

Oct 9, 2018

Study Type

OBSERVATIONAL

Conditions

Lipid-Rich Atherosclerosis of Coronary Artery

Summary

RESSURE-NIRS registry is designed to investigate clinical and pathophysiological characteristics of NIRS-derived lipid-rich plaque in patients with coronary artery disease. This is an on-going multi-center prospective registry in Japan.

Eligibility

Min Age: 20 YearsMax Age: 95 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called near-infrared spectroscopy for people with lipid-rich atherosclerosis of coronary artery. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 20 Years to 95 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEnear-infrared spectroscopy

Near-infrared spectroscopy is an intravascular imaging device to visualize lipid-rich plaque of coronary artery.

Locations(2)

Miyazaki Medical Association Hospital

Miyazaki, Japan

National Cerebral & Cardiovascular Center

Suita, Japan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04864171

Related Trials

Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques

NCT071079711 location